AIMx Podiatry — Advanced Treatment Cash-Pay Options & Support for Practice Growth
Introducing SynaPep™ BPC-157 as the next-generation oral peptide therapy formulated to accelerate soft tissue recovery, reduce inflammation, and promote full-foot function—without injections or complicated protocols.
Unlike standard oral peptides, SynaPep BPC-157 uses a patented lactoferrin-based delivery system that protects the peptide through the digestive tract and enhances absorption via the oral and intestinal mucosa. This means greater bioavailability, faster action, and real clinical results—in a convenient single-dose oral sachet.
Synapep's BPC-157 oral peptide has a patented lactoferrin delivery system that has not been seen before, providing better absorption than other BPC-157 products. With this, your patients can appreciate a treatment that:
